457
On 22/10/2007, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 497. The active ingredient is 4-[3,5-bis(trimethylsilyl)benzamido”> benzoic acid for treatment of hepatocellular carcinoma.